Published in Vaccine Weekly, December 18th, 2002
The pharmaceutical company wants to focus on new immunization technologies such as its experimental nasal spray flu vaccine. But the move means there will only be one company in the United States manufacturing a pneumonia vaccine and another one making an influenza vaccine. Over the last two flu seasons there has been a vaccine shortage.
"It's obviously a concern," Curtis Allen, spokesman for the U.S. Centers for Disease Control and Prevention, said. "The future will depend on the ability of the remaining manufacturers to...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Vaccine Weekly